Humana Past Earnings Performance
Past criteria checks 0/6
Humana's earnings have been declining at an average annual rate of -7.5%, while the Healthcare industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 11.5% per year. Humana's return on equity is 7.7%, and it has net margins of 1.2%.
Key information
-7.5%
Earnings growth rate
-5.7%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 11.5% |
Return on equity | 7.7% |
Net Margin | 1.2% |
Next Earnings Update | 29 Jan 2025 |
Recent past performance updates
Recent updates
Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?
Dec 18Humana: Medicare Advantage Is Just A Short-Term Problem
Dec 05Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Dec 02Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Nov 11Humana - Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over
Nov 05Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Oct 28Positive Sentiment Still Eludes Humana Inc. (NYSE:HUM) Following 30% Share Price Slump
Oct 03Wall Street Lunch: Humana Shares Hit Hard
Oct 02Humana's Falling Share Price Gives Investors An Opportunity
Sep 18Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly
Sep 15Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Aug 19Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact
Jul 24Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings
Jul 16Humana: Medicare Advantage Will Never Be As Profitable As It Was
Jun 23Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885
Jun 20Humana (NYSE:HUM) Will Pay A Dividend Of $0.885
Jun 06Humana Is Set Up For Long-Term Success
Jun 05Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885
May 21Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885
Apr 22Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly
Apr 20Humana: Where To Buy This
Apr 02Humana: This Year's Drop Might Have Created A Buying Opportunity
Mar 19Humana: A Golden Buying Opportunity As Fears Potentially Peaked
Feb 03Humana: The $300 Level Could Get Taken Out In The Near Future
Jan 25Humana: My Oh My, Another Strong Buy
Jan 14Humana: Buy This Powerful Dividend Growth Stock In The New Year
Jan 02Humana: Failed Merger And Other Reasons To Buy
Dec 11Humana: Upgrade To Buy
Oct 06Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did
Sep 27Humana: Mr. Market Got This One Right
Aug 03Humana: Recent Selloff Might Present A Buying Opportunity
Jul 13Humana: Rising Medical Costs Should Be Temporary
Jun 28Humana: Margin Expansion Supported By Growing Memberships
Jun 12Revenue & Expenses Breakdown
How Humana makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 115,010 | 1,359 | 12,801 | 0 |
30 Jun 24 | 112,036 | 1,711 | 12,630 | 0 |
31 Mar 24 | 109,243 | 1,991 | 12,661 | 0 |
31 Dec 23 | 106,374 | 2,489 | 12,627 | 0 |
30 Sep 23 | 102,351 | 3,015 | 12,567 | 0 |
30 Jun 23 | 98,727 | 3,378 | 12,432 | 0 |
31 Mar 23 | 95,642 | 3,115 | 12,291 | 0 |
31 Dec 22 | 92,870 | 2,806 | 12,198 | 0 |
30 Sep 22 | 91,485 | 2,807 | 12,230 | 0 |
30 Jun 22 | 90,512 | 3,143 | 11,854 | 0 |
31 Mar 22 | 87,495 | 3,035 | 11,000 | 0 |
31 Dec 21 | 83,064 | 2,933 | 10,121 | 0 |
30 Sep 21 | 82,201 | 2,673 | 9,794 | 0 |
30 Jun 21 | 80,450 | 2,482 | 9,704 | 0 |
31 Mar 21 | 78,888 | 3,722 | 9,942 | 0 |
31 Dec 20 | 77,155 | 3,367 | 10,052 | 0 |
30 Sep 20 | 74,388 | 4,153 | 9,066 | 0 |
30 Jun 20 | 70,554 | 3,502 | 8,442 | 0 |
31 Mar 20 | 67,716 | 2,614 | 7,791 | 0 |
31 Dec 19 | 64,888 | 2,707 | 7,381 | 0 |
30 Sep 19 | 62,761 | 2,550 | 7,367 | 0 |
30 Jun 19 | 60,726 | 2,505 | 7,378 | 0 |
31 Mar 19 | 58,740 | 1,758 | 7,436 | 0 |
31 Dec 18 | 56,912 | 1,683 | 7,525 | 0 |
30 Sep 18 | 55,933 | 1,512 | 7,135 | 0 |
30 Jun 18 | 55,009 | 1,367 | 6,923 | 0 |
31 Mar 18 | 54,284 | 1,824 | 6,615 | 0 |
31 Dec 17 | 53,767 | 2,448 | 6,419 | 0 |
30 Sep 17 | 53,456 | 1,863 | 6,695 | 0 |
30 Jun 17 | 53,868 | 1,814 | 6,746 | 0 |
31 Mar 17 | 54,341 | 1,475 | 6,992 | 0 |
31 Dec 16 | 54,379 | 614 | 7,173 | 0 |
30 Sep 16 | 54,862 | 1,116 | 7,028 | 0 |
30 Jun 16 | 54,531 | 980 | 6,966 | 0 |
31 Mar 16 | 54,256 | 1,100 | 7,084 | 0 |
31 Dec 15 | 54,289 | 1,276 | 7,295 | 0 |
30 Sep 15 | 53,256 | 1,320 | 7,560 | 0 |
30 Jun 15 | 52,131 | 1,296 | 7,781 | 0 |
31 Mar 15 | 50,621 | 1,209 | 7,799 | 0 |
31 Dec 14 | 48,500 | 1,147 | 7,639 | 0 |
30 Sep 14 | 46,359 | 972 | 7,426 | 0 |
30 Jun 14 | 44,440 | 1,050 | 7,068 | 0 |
31 Mar 14 | 42,539 | 1,126 | 6,694 | 0 |
31 Dec 13 | 41,313 | 1,231 | 6,355 | 0 |
Quality Earnings: HUM has a large one-off loss of $555.0M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: HUM's current net profit margins (1.2%) are lower than last year (2.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HUM's earnings have declined by 7.5% per year over the past 5 years.
Accelerating Growth: HUM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: HUM had negative earnings growth (-54.9%) over the past year, making it difficult to compare to the Healthcare industry average (10.4%).
Return on Equity
High ROE: HUM's Return on Equity (7.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 23:19 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Humana Inc. is covered by 52 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Toung | Argus Research Company |
Hua Ha | Baird |
Ishan Majumdar | Baptista Research |